- Home
- MGOL vs HOTH Comparison
MGOL vs HOTH Comparison
Compare MGOL & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGOL
- HOTH
- Stock Information
- Founded
- MGOL 2018
- HOTH 2017
- Country
- MGOL United States
- HOTH United States
- Employees
- MGOL N/A
- HOTH N/A
- Industry
- MGOL Advertising
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- MGOL Consumer Discretionary
- HOTH Health Care
- Exchange
- MGOL Nasdaq
- HOTH Nasdaq
- Market Cap
- MGOL 7.4M
- HOTH 7.6M
- IPO Year
- MGOL 2023
- HOTH 2019
- Fundamental
- Price
- MGOL $2.38
- HOTH $0.82
- Analyst Decision
- MGOL
- HOTH Strong Buy
- Analyst Count
- MGOL 0
- HOTH 4
- Target Price
- MGOL N/A
- HOTH $4.75
- AVG Volume (30 Days)
- MGOL 70.3K
- HOTH 997.1K
- Earning Date
- MGOL 11-26-2024
- HOTH 11-12-2024
- Dividend Yield
- MGOL N/A
- HOTH N/A
- EPS Growth
- MGOL N/A
- HOTH N/A
- EPS
- MGOL N/A
- HOTH N/A
- Revenue
- MGOL $4,781,886.00
- HOTH N/A
- Revenue This Year
- MGOL N/A
- HOTH N/A
- Revenue Next Year
- MGOL N/A
- HOTH N/A
- P/E Ratio
- MGOL N/A
- HOTH N/A
- Revenue Growth
- MGOL 116.91
- HOTH N/A
- 52 Week Low
- MGOL $1.90
- HOTH $0.58
- 52 Week High
- MGOL $18.30
- HOTH $1.73
- Technical
- Relative Strength Index (RSI)
- MGOL 42.00
- HOTH 42.93
- Support Level
- MGOL $2.30
- HOTH $0.83
- Resistance Level
- MGOL $2.73
- HOTH $0.90
- Average True Range (ATR)
- MGOL 0.14
- HOTH 0.09
- MACD
- MGOL -0.00
- HOTH -0.01
- Stochastic Oscillator
- MGOL 19.00
- HOTH 10.18
About MGOL MGO Global Inc.
MGO Global Inc has built a brand acceleration platform with a focus on the acquisition, optimization and monetization of consumer brands across multiple categories. Its mission is to provide customers with unmatched variety, quality and shopping experience. The Company has three reportable segments: 1) The Messi Store, which sells a range of products under The Messi Brand; 2) Stand Flagpoles, which sells a range of residential flagpoles and related products direct to consumers; and 3) Corporate, which generates no revenue, but reflects corporate expenses related primarily to being a public company.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.